145 related articles for article (PubMed ID: 21454014)
1. QSAR classification models for the prediction of endocrine disrupting activity of brominated flame retardants.
Kovarich S; Papa E; Gramatica P
J Hazard Mater; 2011 Jun; 190(1-3):106-12. PubMed ID: 21454014
[TBL] [Abstract][Full Text] [Related]
2. QSAR modeling and prediction of the endocrine-disrupting potencies of brominated flame retardants.
Papa E; Kovarich S; Gramatica P
Chem Res Toxicol; 2010 May; 23(5):946-54. PubMed ID: 20408563
[TBL] [Abstract][Full Text] [Related]
3. QSAR classification models for the screening of the endocrine-disrupting activity of perfluorinated compounds.
Kovarich S; Papa E; Li J; Gramatica P
SAR QSAR Environ Res; 2012; 23(3-4):207-20. PubMed ID: 22352429
[TBL] [Abstract][Full Text] [Related]
4. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.
Hamers T; Kamstra JH; Sonneveld E; Murk AJ; Kester MH; Andersson PL; Legler J; Brouwer A
Toxicol Sci; 2006 Jul; 92(1):157-73. PubMed ID: 16601080
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47).
Hamers T; Kamstra JH; Sonneveld E; Murk AJ; Visser TJ; Van Velzen MJ; Brouwer A; Bergman A
Mol Nutr Food Res; 2008 Feb; 52(2):284-98. PubMed ID: 18161906
[TBL] [Abstract][Full Text] [Related]
6. QSAR prediction of the competitive interaction of emerging halogenated pollutants with human transthyretin.
Papa E; Kovarich S; Gramatica P
SAR QSAR Environ Res; 2013; 24(4):333-49. PubMed ID: 23710908
[TBL] [Abstract][Full Text] [Related]
7. SAR and QSAR modeling of endocrine disruptors.
Devillers J; Marchand-Geneste N; Carpy A; Porcher JM
SAR QSAR Environ Res; 2006 Aug; 17(4):393-412. PubMed ID: 16920661
[TBL] [Abstract][Full Text] [Related]
8. Binary classification models for endocrine disrupter effects mediated through the estrogen receptor.
Roncaglioni A; Piclin N; Pintore M; Benfenati E
SAR QSAR Environ Res; 2008; 19(7-8):697-733. PubMed ID: 19061085
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship modeling on in vitro endocrine effects and metabolic stability involving 26 selected brominated flame retardants.
Harju M; Hamers T; Kamstra JH; Sonneveld E; Boon JP; Tysklind M; Andersson PL
Environ Toxicol Chem; 2007 Apr; 26(4):816-26. PubMed ID: 17447568
[TBL] [Abstract][Full Text] [Related]
10. New insights into the endocrine disrupting effects of brominated flame retardants.
Legler J
Chemosphere; 2008 Sep; 73(2):216-22. PubMed ID: 18667224
[TBL] [Abstract][Full Text] [Related]
11. QSAR classification of estrogen receptor binders and pre-screening of potential pleiotropic EDCs.
Li J; Gramatica P
SAR QSAR Environ Res; 2010 Oct; 21(7-8):657-69. PubMed ID: 21120754
[TBL] [Abstract][Full Text] [Related]
12. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
Liu H; Papa E; Gramatica P
Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
[TBL] [Abstract][Full Text] [Related]
13. Classification and virtual screening of androgen receptor antagonists.
Li J; Gramatica P
J Chem Inf Model; 2010 May; 50(5):861-74. PubMed ID: 20405856
[TBL] [Abstract][Full Text] [Related]
14. In silico screening of estrogen-like chemicals based on different nonlinear classification models.
Liu H; Papa E; Walker JD; Gramatica P
J Mol Graph Model; 2007 Jul; 26(1):135-44. PubMed ID: 17293141
[TBL] [Abstract][Full Text] [Related]
15. Are brominated flame retardants endocrine disruptors?
Legler J; Brouwer A
Environ Int; 2003 Sep; 29(6):879-85. PubMed ID: 12850103
[TBL] [Abstract][Full Text] [Related]
16. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
Yang W; Mu Y; Giesy JP; Zhang A; Yu H
Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
[TBL] [Abstract][Full Text] [Related]
17. A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes.
Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
Water Res; 2010 Jan; 44(2):373-84. PubMed ID: 19616272
[TBL] [Abstract][Full Text] [Related]
18. Identification of a group of brominated flame retardants as novel androgen receptor antagonists and potential neuronal and endocrine disrupters.
Kharlyngdoh JB; Pradhan A; Asnake S; Walstad A; Ivarsson P; Olsson PE
Environ Int; 2015 Jan; 74():60-70. PubMed ID: 25454221
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and QSAR modeling on multiple endpoints of estrogen activity based on different bioassays.
Liu H; Papa E; Gramatica P
Chemosphere; 2008 Feb; 70(10):1889-97. PubMed ID: 17884132
[TBL] [Abstract][Full Text] [Related]
20. Hormonal activities of new brominated flame retardants.
Ezechiáš M; Svobodová K; Cajthaml T
Chemosphere; 2012 May; 87(7):820-4. PubMed ID: 22236593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
